About OPHTHALMIC THERAPEUTIC INNOVATION LLC
Ophthalmic Therapeutic Innovation, Inc. (OTI) is a company focused on redefining glaucoma patient care through intraocular pressure normalization. They are developing OTI-2024, a first-in-class adenosine drug that acts as a tissue rejuvenation agent.
Development of first-in-class adenosine drugsTissue rejuvenation agent researchGlaucoma patient care innovation
Is this your company?
Claim OPHTHALMIC THERAPEUTIC INNOVATION LLC to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim OPHTHALMIC THERAPEUTIC INNOVATION LLC & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.